Teva intros generic Brovana Inhalation Solution
Arformoterol Tartrate Inhalation Solution is indicated to aid in controlling the symptoms of chronic obstructive pulmonary disease, or COPD, the company said.
Teva is launching a brand-new generic — Arformoterol Tartrate Inhalation Solution.
The generic of Brovana Inhalation Solution, the product is indicated for long-term use and should be taken two times a day to aid in controlling the symptoms of chronic obstructive pulmonary disease, or COPD, the company said.
[Read More: FDA clears Cipla’s generic Brovana]
Designed for use with a nebulizer, Arformoterol Tartrate Inhalation Solution is not used to treat sudden symptoms of COPD, and it is not for the treatment of asthma.
Available in a 15 mcg/2 mL strength, Arformoterol Tartrate Inhalation Solution comes in a carton of 30 individually pouched unit-dose samples.